Aligos Therapeutics
ALGS
59 hedge funds and large institutions have $36M invested in Aligos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 30 closing their positions.
0.03% more ownership
Funds ownership: 2.98% → 3.01% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less funds holding
Funds holding: 76 → 59 (-17)
47% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 30
47% less capital invested
Capital invested by funds: $68.4M → $36M (-$32.3M)
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.1M |
| 2 |
NM
Newtyn Management
New York
|
+$1.31M |
| 3 |
Renaissance Technologies
New York
|
+$735K |
| 4 |
Millennium Management
New York
|
+$631K |
| 5 |
NYLIM
New York Life Investment Management
New York
|
+$295K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$3.7M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.17M |
| 3 |
BlackRock
New York
|
-$1.46M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.01M |
| 5 |
State Street
Boston,
Massachusetts
|
-$467K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
76
ExodusPoint Capital Management
New York
| – | -$25K | -468 | Closed |
|
|
AIG
77
American International Group
New York
| – | -$23K | -419 | Closed |
|
78
Legal & General Group
London,
United Kingdom
| – | -$16K | -313 | Closed |
|
79
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$9 | -177 | Closed |
|
|
AB
80
Amalgamated Bank
New York
| – | -$7K | -138 | Closed |
|
81
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$5K | -99 | Closed |
|
82
US Bancorp
Minneapolis,
Minnesota
| – | -$4K | -72 | Closed |
|
|
AIP
83
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$3K | -59 | Closed |
|
|
PHK
84
Point72 Hong Kong
Hong Kong
| – | -$3K | -53 | Closed |
|
85
Simplex Trading
Chicago,
Illinois
| – | -$2K | -52 | Closed |
|
86
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.73K | -51 | -98% |
|
87
Wells Fargo
San Francisco,
California
| – | -$1.26K | -37 | -88% |
|
ALGS Hedge Fund Activity: Q2 2022 in Review
59 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Aligos Therapeutics (ALGS) for Q2 2022, worth a combined $36M — down 47% from $68.4M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ALGS and 16 opened new positions — a net loss of 14 holders — while 20 trimmed existing stakes and 9 added.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $2.1M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $3.7M sold.
- 59 institutional investors held Aligos Therapeutics (ALGS) as of Q2 2022, down from 76 in Q1 2022.
- Funds reported $36M of Aligos Therapeutics stock for Q2 2022, down 47% quarter-over-quarter.
- 16 funds opened new Aligos Therapeutics positions in Q2 2022 and 30 closed out, a net change of -14 holders.
- The largest Aligos Therapeutics buyer in Q2 2022 was Tang Capital Management, an estimated $2.1M added.
- The largest Aligos Therapeutics seller in Q2 2022 was Janus Henderson Group, an estimated $3.7M sold.
Based on aggregated 13F filings for Q2 2022.